BrightSpring director granted 4,983 RSUs of stock

Wicks Timothy A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Wicks Timothy A reported acquisition or exercise transactions in this Form 4 filing.

BrightSpring Health Services director Timothy A. Wicks received a grant of 4,983 restricted stock units (RSUs) of common stock. The RSUs were granted on May 5, 2026 and fully vest on May 5, 2027. Following this award, Wicks directly holds 25,504 shares of BrightSpring common stock.

Each RSU represents a contingent right to receive one share of common stock upon settlement. Wicks has elected to defer settlement under BrightSpring’s Non-Employee Director Deferred Compensation Plan, so the shares will be delivered after his board service ends or on a future date he previously selected.

Insider Trade Summary

Grant/Award: 4,983 shares

Grant/Award 1 txn

Insider Wicks Timothy A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,983	$0.00	$0.00

Holdings After Transaction: Common Stock — 25,504 shares (Direct)

Footnotes (1)

1. F1. On May 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which fully vest on May 5, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The Reporting Person has elected to defer settlement of the RSUs under the terms of the Issuer's Non-Employee Director Deferred Compensation Plan. Settlement of the RSUs shall be in accordance with the Reporting Person's deferral election form to occur either (1) following the Reporting Person's termination of service from the board of directors or (2) on a future date selected by the Reporting Person at the time of their deferral election.

Key Figures

RSU grant size: 4,983 RSUs Grant price per share: $0.0000 per share Shares held after grant: 25,504 shares +1 more

4 metrics

RSU grant size 4,983 RSUs Restricted stock units granted on May 5, 2026

Grant price per share $0.0000 per share Reported transaction price for the RSU grant

Shares held after grant 25,504 shares Total BrightSpring common shares directly held by Wicks after transaction

RSU vesting date May 5, 2027 Date on which the 4,983 RSUs fully vest

Key Terms

restricted stock units, Non-Employee Director Deferred Compensation Plan, deferral election

3 terms

restricted stock units financial

"the Reporting Person was granted restricted stock units ("RSUs") which fully vest"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Non-Employee Director Deferred Compensation Plan financial

"under the terms of the Issuer's Non-Employee Director Deferred Compensation Plan"

deferral election financial

"in accordance with the Reporting Person's deferral election form"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BrightSpring Health (BTSG) report for Timothy A. Wicks?

BrightSpring Health reported that director Timothy A. Wicks received 4,983 restricted stock units of common stock as a grant. This compensation-related award increased his direct holdings to 25,504 shares after the transaction, without any open-market buying or selling activity.

Are the 4,983 BrightSpring (BTSG) RSUs for Timothy Wicks immediately vested or tradable?

The 4,983 restricted stock units granted to Timothy Wicks are not immediately vested or tradable. They fully vest on May 5, 2027, and each RSU then entitles him to one share of BrightSpring common stock upon settlement under his deferral election.

How did the RSU grant affect Timothy Wicks’ BrightSpring (BTSG) share ownership?

After the RSU grant, Timothy Wicks is reported as directly holding 25,504 shares of BrightSpring common stock. The 4,983 restricted stock units represent additional contingent equity that will convert into shares only when they vest and are settled in the future.

When will Timothy Wicks’ BrightSpring (BTSG) RSUs be settled into shares?

Settlement of Timothy Wicks’ RSUs will occur according to his deferral election. The filing states settlement will take place either after his termination of service from the board or on a future date he selected when making the deferral election.

What is the BrightSpring (BTSG) Non-Employee Director Deferred Compensation Plan mentioned in the filing?

The Non-Employee Director Deferred Compensation Plan allows BrightSpring directors to defer settlement of equity awards. In this case, Timothy Wicks elected to defer settlement of his RSUs so that shares are delivered after his board service ends or on a chosen future date.

Did Timothy Wicks buy or sell BrightSpring (BTSG) shares on the market in this Form 4?

The Form 4 shows a grant of 4,983 restricted stock units to Timothy Wicks with no purchase price, described as a grant or award acquisition. It does not report any open-market purchases or sales of BrightSpring common stock by Wicks on that date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/07/2026 - 06:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wicks Timothy A

(Last) (First) (Middle)

C/O BRIGHTSPRING HEALTH SERVICES, INC.

805 N. WHITTINGTON PARKWAY

(Street)

LOUISVILLE KENTUCKY 40222

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BrightSpring Health Services, Inc. [ BTSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/05/2026		A(1)		4,983	A	$0	25,504	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On May 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which fully vest on May 5, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The Reporting Person has elected to defer settlement of the RSUs under the terms of the Issuer's Non-Employee Director Deferred Compensation Plan. Settlement of the RSUs shall be in accordance with the Reporting Person's deferral election form to occur either (1) following the Reporting Person's termination of service from the board of directors or (2) on a future date selected by the Reporting Person at the time of their deferral election.

	/s/ Jennifer Phipps, as Attorney-in-Fact	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)